Nationwide Life Insurance Fit Review for Type 2 Diabetes

Research Snapshot

Why Nationwide Qualified for This Study

Questions This Section Answers

• Is Nationwide a good choice for life insurance for Type 2 diabetes?
• How many AI platforms named Nationwide for Type 2 diabetes life insurance in 2026?

Nationwide qualified because three of the seven included platforms named it during ranking discovery, and every platform that ranked it placed it second. That is a narrow but consistent showing: 42.9% of included platform responses mentioned the carrier, and no platform ranked it lower than second.

The qualification rests on substance rather than repetition. Nationwide's underwriting questionnaire asks about diabetes diagnosis date, treatment including oral medication or insulin, recent glucose and HbA1c readings, monitoring, physician follow-up, and diabetes complications such as vision problems, ulcers, kidney problems, diabetic coma, or insulin shock ^[1]. Nationwide's underwriting guide explicitly references Type 2/non-insulin-dependent diabetes and states that well-controlled cases may be considered ^[2].

Independent reviewers also placed Nationwide among the best carriers for diabetes in 2026, alongside Banner Life and John Hancock ^[3]. One platform rated the fit "strong" (grok), five rated it "good" (openai, anthropic, google, kimi, perplexity), and one rated it "mixed" (deepseek). That spread is itself a finding: the case for Nationwide is credible but not unanimous.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Type 2 Diabetes

Questions This Section Answers

• Which Nationwide plan should a buyer with Type 2 diabetes choose for term coverage with living benefits?
• Does Nationwide YourLife Guaranteed Level Term include chronic illness benefits for a diabetic buyer?

The most relevant product is Nationwide YourLife Guaranteed Level Term, a temporary term policy that Nationwide identifies as a low-cost, high-death-benefit option and lists as eligible for the Accelerated Death Benefit Rider ^[7]. Platforms consistently pointed to term life with living benefits as the relevant product family ^[8].

The critical product detail is the scope of the living benefit. For Guaranteed Level Term, the publicly identified accelerated benefit is terminal illness with life expectancy of 12 months or less, and the payment reduces the remaining death benefit dollar for dollar ^[7]. Nationwide separately markets chronic-illness, critical-illness, terminal-illness, and long-term-care benefits on certain permanent-life products or policy forms ^[12]. Those are not interchangeable with the terminal-illness rider publicly identified for Guaranteed Level Term.

Platforms disagreed on this point. Some described three living benefits — chronic, critical, and terminal illness — as included at no extra cost on most policies including term ^[15]. Others described the term rider as terminal-illness focused ^[7]. Google reported that chronic and critical illness benefits are unavailable on 10-year term policies and limited to issue ages 18 to 55 on other level term durations ^[20]. A buyer should confirm the exact rider on the exact policy form rather than assume the broader suite applies.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree Nationwide offers for Type 2 diabetes life insurance applicants?
• Is Nationwide's underwriting process for diabetes consistent across AI platform research?

Platforms agreed on four points.

First, Nationwide's underwriting directly addresses diabetes variables. The questionnaire covers diagnosis date, treatment type and dosage, recent glucose and A1C readings, monitoring, physician-visit frequency, and complications ^[22]. Independent underwriting summaries describe the same categories ^[23].

Second, Nationwide uses data-enabled underwriting. Nationwide states that underwriting may use laboratory results, medical history, prescription data, electronic health records, an online interview, and other requirements, with some cases still requiring an exam or labs ^[26]. Google described an "Intelligent Underwriting" program that may let qualifying applicants bypass traditional exams and lab work when digital data supports automated approval ^[27].

Third, no-exam term coverage exists up to $1.5 million for ages 21 to 55, with terms of 10 to 30 years ^[30]. Nationwide's own term page states no medical exam is needed for 10- to 20-year coverage up to $1.5 million with an online process ^[35].

Fourth, Nationwide holds strong financial-strength and complaint metrics. Independent reviews cite an A+ AM Best rating and a NAIC complaint index of 0.08, well below the 1.0 industry baseline ^[36]. These are third-party ratings, not company claims.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Is Nationwide's term policy living benefit chronic illness or only terminal illness?
• Does Nationwide publish A1C thresholds for Type 2 diabetes underwriting?

The largest disagreement concerns living-benefit scope on term. One group of platforms described chronic, critical, and terminal illness riders as included at no extra cost on most policies including term ^[38]. Another described the Guaranteed Level Term rider as terminal-illness only, with broader benefits found on other products or general materials ^[43]. Google added age and term-length restrictions on chronic and critical benefits ^[45]. This conflict is unresolved in the supplied evidence and should be verified against the buyer's exact policy form.

A second uncertainty is underwriting transparency. Nationwide's public underwriting questionnaire is intended for insurance professionals and may not represent every current rule, state, product, or applicant profile ^[47]. Deepseek reported that no verifiable Type 2 diabetes-specific Nationwide underwriting table was located in the sources it reviewed ^[48]. Perplexity noted the public guide gives category rules but not a complete underwriting matrix ^[49].

A third uncertainty is pricing. No platform produced a diabetes-specific Nationwide premium schedule. Public pricing is limited to sample quotes for specific ages, amounts, and health classes ^[50]. One platform reported average monthly rates of $52 for women and $68 for men at age 40 for a 20-year, $500,000 policy with well-controlled diabetes, higher than Banner Life's reported $42 and $54 ^[52]. Those figures are platform-reported and not transferable to an individual applicant.

A fourth uncertainty is outcome evidence. Nationwide provides an underwriting example involving favorable treatment of a client using blood-glucose medication, but this is a company success story, not independent approval-rate data ^[53].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features does Nationwide offer that matter most to a Type 2 diabetes applicant?
• Can a Nationwide term policy be converted to permanent coverage without a new medical exam?

Four features matter most for this buyer.

Diabetes-specific underwriting questions. Nationwide asks about diagnosis timing, treatment, A1C and glucose readings, monitoring, follow-up, and complications ^[54]. Independent summaries confirm these categories drive diabetes underwriting generally ^[55].

Data-enabled and accelerated underwriting. Nationwide describes use of medical history, prescription data, laboratory results, electronic health records, online interviews, and e-applications, with possible exams or labs ^[58]. Google reported an accelerated pathway for qualifying applicants aged 18 to 60 for face amounts from $100,000 up to $1 million or $2 million depending on age ^[59].

Term-to-permanent conversion. Nationwide describes a Term + Perm pathway that may allow eligible term owners to buy permanent coverage without current medical requirements, subject to eligibility rules ^[58]. Independent reviews state Guaranteed Level Term includes a conversion feature to permanent coverage without a new medical exam ^[60]. Google reported conversion rights up to age 65 without new exams ^[62]. Exact deadlines and conversion products must be confirmed in the contract.

Living benefits. Nationwide explains that living benefits may provide access to part of the death benefit while alive, with availability depending on the policy ^[63]. The publicly documented term rider is terminal-illness acceleration at 12 months or less life expectancy, reducing the death benefit dollar for dollar ^[64]. One independent source reported a chronic illness rider maximum of the lesser of 20% of the specified amount or $420 per day in 2025 ^[65].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Nationwide cost per month for a Type 2 diabetes applicant, and are there rider fees?
• What contract terms should a diabetic buyer confirm before paying Nationwide premiums?

No reliable public quote or diabetes-specific premium schedule was found. Premiums depend on age, coverage amount, term length, tobacco status, health history, underwriting class, state, and policy features (openai pricing summary; deepseek pricing summary). Pricing confidence was rated low by openai, deepseek, and perplexity, and moderate by anthropic, grok, kimi, and google.

Reported cost anchors, all platform-reported and scenario-specific:

On fees, platforms reported that living benefits riders are commonly included at no initial cost but reduce the death benefit and cash value if exercised, with a payout reduction greater than 1-for-1 ^[66]. Optional riders such as long-term care, waiver of premium, accidental death benefit, and guaranteed insurability may carry additional charges ^[69]. Administrative fees and death-benefit reductions apply when an accelerated benefit is exercised (google pricing summary).

On contract terms, platforms reported level premiums locked for the selected term of 10, 15, 20, or 30 years, a standard 31-day grace period, a two-year suicide exclusion, and cancellation that terminates coverage without cash value on term policies (anthropic contract summary, google contract summary, perplexity contract summary). Free-look period length was not confirmed in the sources reviewed (deepseek contract summary). Nationwide states that quoted prices are estimates based on sex, age, BMI, and tobacco usage, and that final price may change after underwriting considers the entire health history ^[71].

Best Suited For

Questions This Section Answers

• Who is Nationwide best suited for among Type 2 diabetes life insurance buyers?
• Is Nationwide a good fit for a well-controlled Type 2 diabetic over age 40?

Nationwide is best suited for applicants with stable Type 2 diabetes who can provide recent medical records, A1C results, medication details, and consistent physician follow-up (openai fit assessment). Platforms specifically flagged well-controlled, non-insulin-dependent applicants over age 40 as the group most likely to reach favorable classes such as Standard Plus or Nontobacco Preferred ^[73].

It also suits buyers seeking temporary income-replacement or mortgage-protection coverage with a terminal-illness accelerated death benefit option (openai fit assessment), buyers who value potentially streamlined underwriting using electronic medical, prescription, laboratory, or health-record data (openai strengths), and buyers who want a conversion path to permanent coverage without a new exam ^[77].

Buyers who prioritize low complaint rates and high financial stability alongside term pricing also fit this profile, given the reported 0.08 NAIC complaint index and A+ AM Best rating ^[79].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Nationwide for life insurance with Type 2 diabetes?
• Is Nationwide a poor fit for insulin-dependent or complicated Type 2 diabetes?

Nationwide is probably not best for buyers seeking guaranteed-issue or simplified-issue coverage without meaningful medical underwriting. Nationwide does not offer a guaranteed issue life insurance product ^[81], and one platform reported no final expense or guaranteed issue whole life options ^[82].

It is also a weaker fit for buyers who need a term policy with clearly documented chronic-illness or long-term-care living benefits rather than a terminal-illness benefit (openai probably-not-best-for). Applicants whose diabetes is poorly controlled or has significant kidney, eye, vascular, or cardiovascular complications may face high table ratings or declination unless a broker confirms competitive underwriting from multiple carriers ^[83].

Other limits: no-exam coverage is restricted to ages 21 to 55, so applicants over 55 face full underwriting ^[85]. Coverage above $1.5 million requires a medical exam ^[87]. Nationwide does not publicly advertise a diabetes-specific wellness program or premium discounts tied to continuous glucose monitoring, unlike John Hancock's Aspire program, which one source reported offers up to 25% savings ^[89]. Some policies may be unavailable in certain states such as New York (anthropic limitations).

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Nationwide for a diabetic buyer who needs a diabetes management program?
• When should a Type 2 diabetes buyer choose a different carrier instead of Nationwide?

Another option may be better in five situations.

When the buyer wants a diabetes-specific wellness program with premium discounts. John Hancock's Aspire program was reported to offer virtual health coaching and up to 25% premium savings for active diabetes management ^[91].

When the buyer wants published, carrier-specific Type 2 diabetes underwriting guidelines before applying. Deepseek reported that no verifiable Nationwide Type 2 diabetes underwriting table was located, making pre-assessment difficult ^[93].

When the buyer has higher A1C, recent diagnosis, insulin dependence, or complications and wants carriers known for more favorable chronic-condition underwriting. Platforms named Banner Life and Prudential as allowing standard or table-1 treatment at A1C levels other carriers push to table 3–4 ^[94].

When the buyer needs guaranteed acceptance regardless of health. Mutual of Omaha was reported to offer guaranteed issue whole life for diabetics ^[95].

When the buyer wants the lowest baseline premium and does not need living benefits, or needs coverage above $1.5 million without a medical exam (perplexity better-alternative notes, anthropic limitations).

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Nationwide before signing a Type 2 diabetes life insurance contract?
• Which Nationwide policy details determine whether a diabetic applicant is approved at a favorable rate?

Ten items to confirm directly with Nationwide or an independent broker:

1. Is Nationwide YourLife Guaranteed Level Term currently available in the buyer's state, and what term lengths, face amounts, and conversion rights apply? (openai questions)
2. For the buyer's exact policy form, is the accelerated benefit limited to terminal illness, or are chronic-illness, critical-illness, or long-term-care benefits available? ^[96]
3. How will diagnosis date, latest A1C, glucose readings, medication or insulin use, weight, blood pressure, kidney function, eye health, cardiovascular history, and complications affect the underwriting class? (openai questions, perplexity questions)
4. Will Nationwide require an exam, labs, medical records, prescription-history review, or an attending-physician statement? (openai questions)
5. What premium and underwriting class are offered, and are premiums level for the full term? (openai questions)
6. What are the rider's benefit trigger, maximum acceleration amount, discount or fee formula, interest treatment, and effect on death benefit and policy values? ^[97]
7. What happens if the policy is canceled, lapses, renewed, or converted after an accelerated benefit is paid? (openai questions)
8. What is the exact conversion deadline, and which permanent products are available without new medical underwriting? ^[98]
9. Are there state-specific exclusions, waiting periods, minimum policy amounts, or rider restrictions? (openai questions)
10. Would a broker's comparison of multiple carriers produce a better offer for this particular diabetes profile? (openai questions, deepseek questions)

Final AI Consensus Verdict

Nationwide is a good fit to investigate, not a proven best choice. Its diabetes-focused underwriting questions and data-enabled process are relevant to a stable Type 2 diabetes applicant, and Guaranteed Level Term can provide temporary coverage with a terminal-illness accelerated death benefit. Five platforms rated the fit good, one strong, and one mixed.

The fit becomes mixed if the buyer expects broad chronic-illness or long-term-care living benefits on the term product, needs guaranteed acceptance, or wants verified diabetes-specific pricing. No public evidence establishes that Nationwide is especially competitive for Type 2 diabetes compared with other U.S. carriers, and no diabetes-specific premium examples, underwriting table, approval statistics, or expected rating class were verified. The buyer should obtain a formal Nationwide offer and compare it through an independent broker with multiple carriers. For the broader carrier set, see the Life Insurance for Type 2 Diabetes consensus index, and browse the life insurance category directory for related condition guides.

How This Review Was Produced

This review aggregates fit-research responses from seven AI platforms — openai, anthropic, deepseek, grok, kimi, perplexity, and google — each asked which life insurance carriers are generally worth considering for an adult with Type 2 diabetes who is otherwise in reasonably stable health. The study date is 2026-09-22.

Platform mentions in the ranking stage count only platforms that named Nationwide during ranking discovery. All seven platforms evaluated fit, but only three named Nationwide in the ranking stage. Fit ratings were assigned per platform: good (openai, anthropic, google, kimi, perplexity), strong (grok), and mixed (deepseek).

Citations are platform-reported evidence, not independently verified facts. Company-owned citations materially outnumber independent citations in the supplied material, so company claims should not be read as independently verified. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. No personal testing, customer experience, or independent verification was performed.

Methodology Limitations

Several limitations apply.

Platform-reported research dates differ from the authoritative run date. Deepseek reported 2026-06-01; the other six platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

Deepseek ran with search disabled, so its findings are model-reported rather than retrieved. Its conclusion that no verifiable Nationwide Type 2 diabetes underwriting table was located reflects the sources it reviewed, not proof that no such table exists.

The deterministic identity audit noted that official-site retrieval failed for one or more mentions and that a product-labeled company mention was merged using matching company-name and supplied-domain signatures. Official-page excerpts retrieved for this run were not verified and included unrelated business-insurance content, so they were not used as evidence for life insurance claims.

Conflicting product names, pricing, and capabilities were not resolved by guessing. The living-benefit scope conflict on Guaranteed Level Term remains open. No public evidence establishes diabetes-specific approval odds, rate competitiveness, or a guaranteed acceptance standard. The exact availability of the recommended policy and riders in the buyer's state is unclear. Medical underwriting remains material; stable Type 2 diabetes does not ensure standard, preferred, or any particular offer.